Navigation Links
JHP Pharmaceuticals and Putney Inc. Announce Multi-Year Contract Manufacturing Agreement
Date:1/27/2011

PARSIPPANY, N.J., Jan. 27, 2011 /PRNewswire/ -- JHP Pharmaceuticals, a leading provider of contract manufacturing services for sterile injectable products announced today that it has entered into a multi-year contract with Putney, Inc., a well-established and growing provider of veterinary pharmaceutical products. JHP will be responsible for manufacturing and supply of a lyophilized veterinary product.

Jean Hoffman, CEO and founder of Putney said, "We are pleased to partner with JHP Pharmaceuticals in the manufacture and supply of this significant product in veterinary healthcare."

Commenting on JHP's selection for this multi-year manufacturing contract, Stuart Hinchen president and cofounder of JHP stated, "We are very pleased that JHP was chosen by Putney. Our experienced staff, customer centric approach and cGMP compliance record will allow us to effectively serve this important customer."

Hinchen also noted, "As part of our ongoing investment in our Rochester facility, we are completing the installation and qualification of a new 240 sq. ft. lyophilizer. The new lyophilizer and recent agreements demonstrate our steady growth in both number of contract customers and facility capabilities. The Rochester, Michigan manufacturing site has a solid history of successful partnerships, manufacturing both clinical and commercial products.

Management at both companies sees this agreement as a positive cooperation focused on quality-driven pharmaceutical products improving patient health.

About JHP Pharmaceuticals, LLCJHP Pharmaceuticals, headquartered in New Jersey, provides contract manufacturing of sterile injectables, biologics, vaccines, ophthalmics and otics for large and small pharmaceutical and biotech organizations.

JHP's sterile manufacturing facility, located in Rochester Michigan sits on over 80 acres of land and includes a 171,000 sq. ft. production building and warehouse. The production facility utilizes three high-speed filling lines, four lyophilizers and a clinical fill line. The site also includes separate facilities for chemistry, sterility testing, and analytical methods development.

JHP has the capability to manufacture small-scale clinical through large-scale commercial products. JHP employs more than 330 staff in the USA in its manufacturing, product development, sales & marketing and corporate areas. For more information, please visit www.jhppharma.com.

About Putney Inc.Putney is a pharmaceutical company committed to providing high quality, cost-effective generic medicines for pets. Putney's reliable supply of affordable drug options empowers veterinarians, allowing them to provide the best possible medicine at the best possible price, and supports pet owners, helping them afford to comply with veterinary recommendations. Putney's ongoing investment in research and development is focused on creating the next generation of generic veterinary products based on inputs from companion animal veterinarians and its industry partners. Learn more at www.putneyvet.com.Contact:Dan Leone973.658.3559Bill Conway877.906.7556jhpcontractservices@jhppharma.com
'/>"/>

SOURCE JHP Pharmaceuticals, LLC
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. AVANIR Pharmaceuticals Invites Investors to Fiscal 2011 First Quarter Conference Call
2. Amylin Pharmaceuticals Reports 2010 Financial Results
3. Prolong Pharmaceuticals Leases 24,000-Square-Foot Manufacturing Facility, Adds Facilities Veteran to Executive Team
4. Savient Pharmaceuticals Names John H. Johnson Chief Executive Officer
5. Merrimack Pharmaceuticals Announces the Addition of Michael Porter to its Board of Directors
6. Optimer Pharmaceuticals Announces FDA Acceptance of NDA for Filing and Designation of Priority Review for Fidaxomicin for the Treatment of Clostridium difficile Infection (CDI)
7. CureFAKtor Pharmaceuticals Demonstrates that Novel Focal Adhesion Kinase (FAK) Inhibitors Targeted to Protein-Protein Binding Sites Inhibit Pancreatic Cancer Cells Growth
8. Amylin Pharmaceuticals to Webcast Year-End Financial Results
9. ADVENTRX Pharmaceuticals Receives PDUFA Date for Exelbine™ NDA
10. Federal Government Obtains Permanent Injunction Against Deltex Pharmaceuticals Inc.
11. AVANIR Pharmaceuticals Announces NASDAQ Opening Bell Ceremony
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... , June 24, 2016 ... Market by Type (Standard Pen Needles, Safety Pen Needles), ... (Insulin, GLP-1, Growth Hormone), Mode of Purchase (Retail, Non-Retail) ... MarketsandMarkets, This report studies the market for the forecast ... to reach USD 2.81 Billion by 2021 from USD ...
(Date:6/24/2016)...  Arkis BioSciences, a leading innovator in the ... cerebrospinal fluid treatments, today announced it has secured ... led by Innova Memphis, followed by Angel Capital ... Arkis, new financing will accelerate the commercialization of ... of its in-licensed Endexo® technology. ...
(Date:6/23/2016)... 23, 2016 Any dentist who has made an ... current process. Many of them do not even offer this ... and high laboratory costs involved. And those who ARE able ... such a high cost that the majority of today,s patients ... Parsa Zadeh , founder of Dental Evolutions Inc. and ...
Breaking Medicine Technology:
(Date:6/27/2016)... Brooklyn, NY (PRWEB) , ... June 27, 2016 ... ... is using cutting edge technology to revolutionize the emergency ambulance transport experience for ... Many are aware of how Uber has disrupted the taxi industry through the ...
(Date:6/26/2016)... ... June 26, 2016 , ... Pixel Film Studios Released ProSlice Levels, a Media ... give their videos a whole new perspective by using the title layers in ... Studios. , ProSlice Levels contains over 30 Different presets to choose from. ...
(Date:6/25/2016)... ... June 25, 2016 , ... Experts from the American Institutes ... Research Meeting June 26-28, 2016, at the Hynes Convention Center in Boston. , ... advance care planning, healthcare costs and patient and family engagement. , AIR researchers ...
(Date:6/25/2016)... ... June 25, 2016 , ... First Choice Emergency ... named Dr. Sesan Ogunleye, as the Medical Director of its new Mesquite-Samuell Farm facility. ... Director of our new Mesquite location,” said Dr. James M. Muzzarelli, Executive Medical Director ...
(Date:6/25/2016)... ... June 25, 2016 , ... Conventional wisdom preaches the ... In terms of the latter, setting the bar too high can result in disappointment, ... just slow progress toward their goal. , Research from PsychTests.com reveals ...
Breaking Medicine News(10 mins):